The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene.

We have cloned the genomic breakpoints for a balanced t(14;21)(q11. 2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia. Sequence analysis of the genomic breakpoints indicated that the translocation had been mediated by an illegitimate V(D)J recombination event that disrupted the T-cell receptor (TCR) alpha locus and placed the TCR alpha locus enhancer on the derivative 21 chromosome. We identified a previously unreported transcript, designated BHLHB1 (for basic domain, helix-loop-helix protein, class B, 1) that had been activated by the translocation. BHLHB1 mapped to the region of chromosome 21 that has been proposed to be responsible, at least in part, for the learning deficits seen in children with Down's syndrome. Although BHLHB1 expression normally is restricted to neural tissues, T-cell lymphoblasts with the t(14;21)(q11.2;q22) also expressed high levels of BHLHB1 mRNA. Expression of BHLHB1 dramatically inhibited E2A-mediated transcription activation in NIH 3T3 fibroblasts and Jurkat T cells. This observation suggests that BHLHB1, similar to SCL/TAL1, may exert a leukemogenic effect through a functional inactivation of E2A or related proteins.

[1]  Xiao-Hong Sun,et al.  Massive Apoptosis of Thymocytes in T-Cell-Deficient Id1 Transgenic Mice , 1999, Molecular and Cellular Biology.

[2]  K. Gross,et al.  Disordered T-Cell Development and T-Cell Malignancies in SCL LMO1 Double-Transgenic Mice: Parallels with E2A-Deficient Mice , 1999, Molecular and Cellular Biology.

[3]  G. Nolan,et al.  Growth Inhibition and Apoptosis Due to Restoration of E2A Activity in T Cell Acute Lymphoblastic Leukemia Cells , 1999, The Journal of experimental medicine.

[4]  S. Artavanis-Tsakonas,et al.  Notch Inhibition of E47 Supports the Existence of a Novel Signaling Pathway , 1998, Molecular and Cellular Biology.

[5]  Xiao-Hong Sun,et al.  The Tal1 Oncoprotein Inhibits E47-mediated Transcription , 1998, The Journal of Biological Chemistry.

[6]  R. Benezra,et al.  High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice , 1997, Molecular and cellular biology.

[7]  D. Pinkel,et al.  E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas , 1997, Molecular and cellular biology.

[8]  J. Strominger,et al.  The Translin Ring Specifically Recognizes DNA Ends at Recombination Hot Spots in the Human Genome* , 1997, The Journal of Biological Chemistry.

[9]  S. Thandla,et al.  Molecular biology of acute lymphocytic leukemia. , 1997, Seminars in oncology.

[10]  T. Kadesch,et al.  Selective utilization of basic helix-loop-helix-leucine zipper proteins at the immunoglobulin heavy-chain enhancer , 1997, Molecular and cellular biology.

[11]  M. Stanulla,et al.  Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. , 1996, Blood.

[12]  M. Peyton,et al.  BETA3, a novel helix-loop-helix protein, can act as a negative regulator of BETA2 and MyoD-responsive genes , 1996, Molecular and cellular biology.

[13]  R. Bronson,et al.  A mouse model for Down syndrome exhibits learning and behaviour deficits , 1995, Nature Genetics.

[14]  A. Omori,et al.  A novel gene, Translin, encodes a recombination hotspot binding protein associated with chromosomal translocations , 1995, Nature Genetics.

[15]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[16]  F. Lee,et al.  The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Hsu,et al.  Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Winoto,et al.  A locus control region in the T cell receptor alpha/delta locus. , 1994, Immunity.

[19]  S. Korsmeyer,et al.  Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. , 1992, Annual review of immunology.

[20]  R. Espinosa,et al.  TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  W. Ludwig,et al.  TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). , 1991, Oncogene.

[22]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.

[23]  H. Hsu,et al.  Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins , 1991, Molecular and cellular biology.

[24]  M. Perutz,et al.  The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Carroll,et al.  The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix‐loop‐helix protein. , 1990, The EMBO journal.

[26]  T. Waldmann,et al.  The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Aurias,et al.  Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Cleary,et al.  lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif , 1989, Cell.

[29]  P. Nowell,et al.  Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Waldmann,et al.  Demonstration of delta rec-pseudo J alpha rearrangement with deletion of the delta locus in a human stem-cell leukemia , 1989, The Journal of experimental medicine.

[31]  S. Korsmeyer,et al.  The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein , 1989, Molecular and cellular biology.

[32]  T. Waldmann,et al.  Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Jun Ma,et al.  GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.

[34]  M. Ptashne,et al.  GAL4 activates gene expression in mammalian cells , 1988, Cell.

[35]  P. Nowell,et al.  Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias. , 1986, Science.